| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ADVISORY BRD CO COM | 26,698 | 1,324,000 | 0.20% | ||
| 52 | SUMMIT THERAPEUTICS PLC | 117,841 | 1,355,000 | 0.20% | ||
| 53 | GENERAL MTRS CO | 90,000 | 1,472,000 | 0.22% | ||
| 54 | Intersect ENT Inc | 67,500 | 1,519,000 | 0.23% | ||
| 55 | * XUEDA ED GROUP SPONSORED ADR | 331,274 | 1,789,000 | 0.27% | ||
| 56 | FIVE PRIME THERAPEUTICS INC | 45,900 | 1,905,000 | 0.29% | ||
| 57 | ALIBABA GROUP HLDG LTD | 24,500 | 1,991,000 | 0.30% | ||
| 58 | VALEANT PHARMACEUTICALS INTL | 20,000 | 2,033,000 | 0.30% | ||
| 59 | PHYSICIANS RLTY TR | 122,227 | 2,061,000 | 0.31% | ||
| 60 | CHINA BIOLOGIC PRODS INC | 15,300 | 2,180,000 | 0.33% | ||
| 61 | GENERAL MTRS CO | 65,000 | 2,211,000 | 0.33% | ||
| 62 | MALLINCKRODT PUB LTD CO | 30,000 | 2,239,000 | 0.34% | ||
| 63 | LAS VEGAS SANDS CORP | 55,500 | 2,433,000 | 0.36% | ||
| 64 | AMAZON COM INC | 3,780 | 2,555,000 | 0.38% | ||
| 65 | Strongbridge Biopharma plc | 388,945 | 2,679,000 | 0.40% | ||
| 66 | CELGENE CORP | 22,778 | 2,728,000 | 0.41% | ||
| 67 | NOKIA CORP | 400,000 | 2,808,000 | 0.42% | ||
| 68 | INTEGRATED DEVICE TECHNOLOGY | 108,000 | 2,846,000 | 0.43% | ||
| 69 | ADAMAS PHARMACEUTICALS INC | 100,631 | 2,850,000 | 0.43% | ||
| 70 | ENANTA PHARMACEUTICALS INC | 90,000 | 2,972,000 | 0.44% | ||
| 71 | AERIE PHARMACEUTICALS INC COM | 135,000 | 3,287,000 | 0.49% | ||
| 72 | LIFELOCK ORD | 252,945 | 3,630,000 | 0.54% | ||
| 73 | ARIAD PHARMACEUTICALS ORD (NMS) | 581,215 | 3,633,000 | 0.54% | ||
| 74 | ADEPTUS HEALTH INC | 75,000 | 4,089,000 | 0.61% | ||
| 75 | HIMAX TECHNOLOGIES INC | 500,000 | 4,100,000 | 0.61% | ||
| 76 | TEEKAY CORPORATION | 500,000 | 4,935,000 | 0.74% | ||
| 77 | FACEBOOK INC | 58,200 | 6,091,000 | 0.91% | ||
| 78 | NEVRO CORP COM | 125,000 | 8,439,000 | 1.26% | ||
| 79 | POWERSHARES QQQ TRUST | 300,000 | 33,558,000 | 5.02% | Put | |
| 80 | SPDR S&P 500 ETF TR | 2,540,000 | 517,830,000 | 77.52% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001599562-16-000008, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
